Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chi-Feng Chung"'
Autor:
Lai-Wan Hsu, Jian-Hong Liu, Kun-Long Chen, Pei-Ching Chen, Kuo Lung Lian, Hong-En Chiang, Zhi-Kai Fan, Zhao-Yin Chen, Chung-Liang Cheng, Chi-Feng Chung, Yuan-Ching Tu
Publikováno v:
IEEE Open Access Journal of Power and Energy, Vol 11, Pp 254-265 (2024)
The seismic resilience has become a critical concern for power systems for high-impact, low-probability disasters such as severe earthquakes. In order to enhance seismic resilience for power systems, a novel protective device, the Passive Over-Curren
Externí odkaz:
https://doaj.org/article/8258b23ab45d4c708177efe521fa1a81
Autor:
Wei-Hsin Liu, Mei-Ching Liu, Ben-Long Yu, Skye Hung-Chun Cheng, Ming-Yuan Li, Chi-Feng Chung, Tzung-De Wang, Chi-Feng Hung
Publikováno v:
Journal of Cancer Research and Practice, Vol 1, Iss 2, Pp 163-171 (2014)
Trastuzumab, a humanized monoclonal antibody directed against the external domain of the HER-2 protein, has shown remarkable activity against HER-2 positive breast cancer. Consequently, the use of adjuvant trastuzumab plus chemotherapy in patients wi
Externí odkaz:
https://doaj.org/article/40844b67f3e14d0b833ba00c0178181c
Autor:
Chi-Feng Chung, 鍾奇峰
105
In recent years,3C digital products technical has progressed rapidly.Radiating plays an important role in product design to ensure product efficiency. Current digital products are still using heat sink or cooling fan as main cooling source f
In recent years,3C digital products technical has progressed rapidly.Radiating plays an important role in product design to ensure product efficiency. Current digital products are still using heat sink or cooling fan as main cooling source f
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/hzspqb
Autor:
Chi-Feng Chung, 鍾季峰
94
Internet and E-Commerce of widely accepted, than the traditional economic mode make the customer descend to expect to acquire sooner and soon and high-quality consultation service, according to the inquisition of the company of PwC Consulting
Internet and E-Commerce of widely accepted, than the traditional economic mode make the customer descend to expect to acquire sooner and soon and high-quality consultation service, according to the inquisition of the company of PwC Consulting
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/75977411019533679924
Autor:
Takayuki Ueno, Louis W.C. Chow, Wonshik Han, Chiun Sheng Huang, G Bruce Mann, Satoshi Morita, Hironori Haga, Elham Fakhrejahani, Takayuki Kobayashi, Kenichi Inoue, Mariko Tokiwa, Hirofumi Suwa, Tomoyuki Aruga, Sachiko Minamiguchi, Yosuke Yamada, Yuko Tanabe, Masahiro Takada, Toshinari Yamashita, Hiroji Iwata, Chi-Feng Chung, Sachiko Takahara, Eriko Tokunaga, Shigeru Imoto, Eun Sook Lee, Yasuaki Sagara, Jee Hyun Kim, Richard H DeBoer, Hyun-Ah Kim, Hung Wen Lai, Ming-Feng Hou, Michelle White, Yoshiko Umeyama
Publikováno v:
Cancer Research. 83:P5-09
Background: Early biologic response to endocrine therapy, such as changes in Ki67 labeling index (LI), has been suggested to predict long-term outcomes in hormone sensitive breast cancer. The addition of a CDK4/6 inhibitor to endocrine therapy has be
Autor:
Javier, Cortés, Sung-Bae, Kim, Wei-Pang, Chung, Seock-Ah, Im, Yeon Hee, Park, Roberto, Hegg, Min Hwan, Kim, Ling-Ming, Tseng, Vanessa, Petry, Chi-Feng, Chung, Hiroji, Iwata, Erika, Hamilton, Giuseppe, Curigliano, Binghe, Xu, Chiun-Sheng, Huang, Jee Hyun, Kim, Joanne W Y, Chiu, Jose Luiz, Pedrini, Caleb, Lee, Yali, Liu, Jillian, Cathcart, Emarjola, Bako, Sunil, Verma, Sara A, Hurvitz, Gail, Wright
Publikováno v:
New England Journal of Medicine. 386:1143-1154
Trastuzumab emtansine is the current standard treatment for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer whose disease progresses after treatment with a combination of anti-HER2 antibodies and a taxa
Autor:
Myong Cheol Lim, Jung-Yun Lee, Yong-Man Kim, Michael Gold, Lucy Gilbert, Lukas Rob, Yong Beom Kim, Jae-Weon Kim, Peng-Hui Wang, Min Hwan Kim, Yu-Fang Huang, Chi-Feng Chung, Sunil Gupta, Srinivasa Rao Jada, Angeles Alvarez Secord
Publikováno v:
Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology.
Autor:
Toshimi Takano, Javier Cortes, David W. Cescon, Seock-Ah Im, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Valia Karantza, Hope S. Rugo, Peter Schmid
Publikováno v:
Annals of Oncology. 33:S465
Autor:
Yuan-Ching Chang, Ming-Yang Wang, Chiun-Sheng Huang, Yi-Hsuan Lee, Chiao Lo, Po-Sheng Yang, Jason Lei, Skye Hung-Chun Cheng, Chi-Feng Chung, Ben-Long Yu, Li Wei Tsai, Kuan-Hui Shih
Publikováno v:
Japanese Journal of Clinical Oncology
Background The information of Oncotype DX applied in Asian breast cancer patients is limited. A recurrence index for distant recurrence (RI-DR) has been developed for early-stage breast cancer (EBC) from tumor samples in Chinese patients. In this stu
Autor:
Sara Hurvitz, Sung-Bae Kim, Wei-Pang Chung, Seock-Ah Im, Yeon Hee Park, Roberto Hegg, Min-Hwan Kim, Ling-Ming Tseng, Vanessa Petry, Chi-Feng Chung, Hiroji Iwata, Erika Hamilton, Giuseppe Curigliano, Binghe Xu, Caleb Lee, Yali Liu, Jillian Cathcart, Emarjola Bako, Sunil Verma, Javier Cortés
Publikováno v:
Cancer Research. 82:GS3-01
Background: T-DXd is a HER2-targeting antibody-drug conjugate approved for the treatment of pts with advanced HER2+ mBC based on the DESTINY-Breast01 study (NCT03248492). DESTINY-Breast03 (NCT03529110) isa randomized, multicenter, open-label, phase 3